Immediate Impact
55 standout
Citing Papers
Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Qiao Li being referenced
The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial
2024 Standout
Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Qiao Li | 929 | 518 | 756 | 644 | 147 | 2.0k | |
| Jianxin Xue | 766 | 744 | 415 | 767 | 135 | 2.2k | |
| F. William Orr | 1221 | 436 | 766 | 1184 | 77 | 2.9k | |
| Qingyuan Zhang | 1333 | 605 | 760 | 1252 | 134 | 2.9k | |
| Yasuo Hozumi | 944 | 511 | 686 | 321 | 84 | 1.9k | |
| Toru Kumagai | 1381 | 1356 | 733 | 1042 | 154 | 3.1k | |
| Carmine Carbone | 892 | 372 | 525 | 1132 | 83 | 2.3k | |
| Shuang Liu | 519 | 259 | 613 | 1087 | 125 | 2.2k | |
| Riccardo Giampieri | 1237 | 684 | 578 | 680 | 121 | 2.2k | |
| Ling Xu | 487 | 227 | 1100 | 1138 | 127 | 2.2k | |
| Daniel G. Stover | 1413 | 635 | 750 | 1234 | 143 | 2.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...